TransMedics Group Inc (TMDX)

Return on total capital

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Earnings before interest and tax (EBIT) (ttm)	US$ in thousands	39,412	36,320	9,058	-1,925	-15,880	-29,042	-12,323	-24,562	-32,624	-38,603	-43,957	-42,940	-40,305	-33,962	-26,099	-23,892	-24,731	-27,505	-30,580	-31,162
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	228,603	209,920	189,894	159,471	137,202	126,460	145,213	192,625	187,375	187,857	50,919	59,910	67,854	78,549	88,983	97,675	103,891	109,550	113,760	46,683
Return on total capital		17.24%	17.30%	4.77%	-1.21%	-11.57%	-22.97%	-8.49%	-12.75%	-17.41%	-20.55%	-86.33%	-71.67%	-59.40%	-43.24%	-29.33%	-24.46%	-23.80%	-25.11%	-26.88%	-66.75%

December 31, 2024 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $39,412K ÷ ($—K + $228,603K)
= 17.24%

TransMedics Group Inc's return on total capital has shown a downward trend from March 31, 2020, to June 30, 2022, with negative percentages ranging from -66.75% to -86.33%. However, starting from September 30, 2022, there was an improvement in the return on total capital. The percentages ranged from -20.55% to 17.30% as of December 31, 2024. This indicates a recovery in the company's efficiency in generating profits relative to the total capital employed. Investors and stakeholders may find the recent positive trend promising for the company's financial performance and capital utilization.